Literature DB >> 31865871

Outcome Measures for Functional Neurological Disorder: A Review of the Theoretical Complexities.

Timothy R Nicholson1, Alan Carson1, Mark J Edwards1, Laura H Goldstein1, Mark Hallett1, Bridget Mildon1, Glenn Nielsen1, Clare Nicholson1, David L Perez1, Susannah Pick1, Jon Stone1.   

Abstract

The development and selection of optimal outcome measures is increasingly recognized as a key component of evidence-based medicine, particularly the need for the development of a standardized set of measures for use in clinical trials. This process is particularly complex for functional neurological disorder (FND) for several reasons. FND can present with a wide range of symptoms that resemble the full spectrum of other neurological disorders. Additional physical (e.g., pain, fatigue) and psychological (e.g., depression, anxiety) symptoms are commonly associated with FND, which also can be highly disabling with implications for prognosis, and warrant concurrent assessment, despite an unclear etiological relationship with FND. Furthermore, several unique clinical aspects of FND make it likely that the usual prioritization of "objective" (or clinician-rated) over "subjective" (or patient-rated) measures might not be appropriate. Self-report measures may be more clinically meaningful in this patient population. Despite being a common and disabling disorder, there has been little research into outcome measures in FND, and to date trials have largely used measures designed for the assessment of other disorders. An international FND Core Outcome Measure group (FND-COM) has been established to develop a consensus battery of outcomes for FND: a "core outcome set." In this perspective article, the authors reviewed the process of outcome measure development and selection before considering the specific features of FND affecting the development of a core outcome set, as well as a research agenda to optimize outcome measurement in this complex neuropsychiatric disorder.

Entities:  

Keywords:  Conversion Disorder; Functional Neurological Disorder; Outcome Measure; Psychogenic

Mesh:

Year:  2019        PMID: 31865871     DOI: 10.1176/appi.neuropsych.19060128

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  15 in total

1.  Shared Individual Formulation Therapy (SIFT): an open-label trial of a new therapy accommodating patient heterogeneity in functional neurological disorder.

Authors:  M Gutkin; R J Brown; L McLean; J Streimer; R A Kanaan
Journal:  J Neurol       Date:  2021-09-19       Impact factor: 4.849

2.  Attention impairment in motor functional neurological disorders: a neuropsychological study.

Authors:  Gabriela Věchetová; Tomáš Nikolai; Matěj Slovák; Zuzana Forejtová; Marek Vranka; Eva Straková; Tiago Teodoro; Evžen Růžička; Mark J Edwards; Tereza Serranová
Journal:  J Neurol       Date:  2022-07-17       Impact factor: 6.682

3.  Functional Neurologic Disorders: The Need for a Model of Care.

Authors:  Mary A O'Neal; Gaston C Baslet; Ginger R Polich; Geoffrey S Raynor; Barbara A Dworetzky
Journal:  Neurol Clin Pract       Date:  2021-04

4.  Botulinum neurotoxin (BoNT) treatment in functional movement disorders: long-term follow-up.

Authors:  Yasmine Em Dreissen; Franka Lambert; Joke M Dijk; Johannes Htm Koelman; Marina Aj Tijssen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-07-13       Impact factor: 10.154

Review 5.  Subjective versus objective measures of distress, arousal and symptom burden in patients with functional seizures and other functional neurological symptom disorder presentations: A systematic review.

Authors:  Joy Adewusi; Liat Levita; Cordelia Gray; Markus Reuber
Journal:  Epilepsy Behav Rep       Date:  2021-11-09

6.  Outcome measurement in functional neurological disorder: a systematic review and recommendations.

Authors:  Susannah Pick; David G Anderson; Ali A Asadi-Pooya; Selma Aybek; Gaston Baslet; Bastiaan R Bloem; Abigail Bradley-Westguard; Richard J Brown; Alan J Carson; Trudie Chalder; Maria Damianova; Anthony S David; Mark J Edwards; Steven A Epstein; Alberto J Espay; Béatrice Garcin; Laura H Goldstein; Mark Hallett; Joseph Jankovic; Eileen M Joyce; Richard A Kanaan; Roxanne C Keynejad; Kasia Kozlowska; Kathrin LaFaver; W Curt LaFrance; Anthony E Lang; Alex Lehn; Sarah Lidstone; Carine W Maurer; Bridget Mildon; Francesca Morgante; Lorna Myers; Clare Nicholson; Glenn Nielsen; David L Perez; Stoyan Popkirov; Markus Reuber; Karen S Rommelfanger; Petra Schwingenshuh; Tereza Serranova; Paul Shotbolt; Glenn T Stebbins; Jon Stone; Marina Aj Tijssen; Michele Tinazzi; Timothy R Nicholson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-02-28       Impact factor: 10.154

7.  Trial Of Neurostimulation In Conversion Symptoms (TONICS): a feasibility randomised controlled trial of transcranial magnetic stimulation for functional limb weakness.

Authors:  Susannah Pick; John Hodsoll; Biba Stanton; Amy Eskander; Ioannis Stavropoulos; Kiran Samra; Julia Bottini; Hena Ahmad; Anthony S David; Alistair Purves; Timothy R Nicholson
Journal:  BMJ Open       Date:  2020-10-06       Impact factor: 2.692

8.  The chronnectome as a model for Charcot's 'dynamic lesion' in functional movement disorders.

Authors:  Ramesh S Marapin; A M Madelein van der Stouwe; Bauke M de Jong; Jeannette M Gelauff; Victor M Vergara; Vince D Calhoun; Jelle R Dalenberg; Yasmine E M Dreissen; Johannes H T M Koelman; Marina A J Tijssen; Harm J van der Horn
Journal:  Neuroimage Clin       Date:  2020-08-13       Impact factor: 4.881

Review 9.  Neuroimaging in Functional Neurological Disorder: State of the Field and Research Agenda.

Authors:  David L Perez; Timothy R Nicholson; Ali A Asadi-Pooya; Indrit Bègue; Matthew Butler; Alan J Carson; Anthony S David; Quinton Deeley; Ibai Diez; Mark J Edwards; Alberto J Espay; Jeannette M Gelauff; Mark Hallett; Silvina G Horovitz; Johannes Jungilligens; Richard A A Kanaan; Marina A J Tijssen; Kasia Kozlowska; Kathrin LaFaver; W Curt LaFrance; Sarah C Lidstone; Ramesh S Marapin; Carine W Maurer; Mandana Modirrousta; Antje A T S Reinders; Petr Sojka; Jeffrey P Staab; Jon Stone; Jerzy P Szaflarski; Selma Aybek
Journal:  Neuroimage Clin       Date:  2021-03-11       Impact factor: 4.881

Review 10.  Neurostimulation for the treatment of functional neurological disorder: A systematic review.

Authors:  Irene Gonsalvez; Primavera Spagnolo; Barbara Dworetzky; Gaston Baslet
Journal:  Epilepsy Behav Rep       Date:  2021-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.